文献速递母胎医学产科

TTTS Ⅰ期与Ⅱ期、Ⅲ期与Ⅳ期的区分不影响激光术后双胎存活概率

Differentiation between TTTS Stages I vs II and III vs IV does not affect probability of double survival after laser therapy.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-07-09

该单中心研究纳入1995年至2013年接受胎儿镜激光手术的1020例严重双胎输血综合征(TTTS)单绒毛膜双胎妊娠,平均孕周20.8±2.2周。按Quintero分期分析围产儿结局,发现双胎存活率与分期显著相关,但Ⅰ期与Ⅱ期之间、Ⅲ期与Ⅳ期之间存活率无显著差异。

要点

  • 双胎存活率在Ⅰ期69.0%、Ⅱ期71.4%、Ⅲ期55.4%、Ⅳ期51.0%。
  • Ⅰ期与Ⅱ期、Ⅲ期与Ⅳ期之间存活率无显著差异。
  • 合并Ⅰ+Ⅱ期双胎存活率70.6%,显著高于合并Ⅲ+Ⅳ期的54.9%。

核心结论

  • TTTS单绒毛膜双胎妊娠激光术后的双胎存活和至少一胎存活与Quintero分期显著相关。
  • 区分Ⅰ期与Ⅱ期、Ⅲ期与Ⅳ期对围产儿存活无显著预后意义。

研究设计与样本

  • 单中心研究,纳入1020例连续严重TTTS病例,均接受胎儿镜激光手术。
  • 研究期间为1995年1月至2013年3月,纳入时平均孕周20.8±2.2周。

主要发现

  • 已知结局的1019例中,双胎存活率:Ⅰ期69.0%(127/184)、Ⅱ期71.4%(257/360)、Ⅲ期55.4%(236/426)、Ⅳ期51.0%(25/49)。
  • 至少一胎存活率:Ⅰ期91.3%(168/184)、Ⅱ期89.7%(323/360)、Ⅲ期83.1%(354/426)、Ⅳ期77.6%(38/49)。
  • Ⅱ期与Ⅲ期比较,双胎存活率P<0.001,至少一胎存活率P=0.011。
  • 合并Ⅰ+Ⅱ期双胎存活率70.6%(384/544)vs 合并Ⅲ+Ⅳ期54.9%(261/475),P<0.001;至少一胎存活率90.3%(491/544)vs 82.5%(392/475),P<0.001。
  • 连续亚组分析中,Ⅰ+Ⅱ期双胎存活率从59.8%(55/92)升至75.0%(96/128),aOR线性趋势1.26(95%CI 1.01-1.56),P=0.037;Ⅲ+Ⅳ期从41.7%(45/108)升至62.0%(57/92),aOR线性趋势1.21(95%CI 0.98-1.50),P=0.082。

关键数值与推荐

  • 双胎存活率最低见于Ⅲ期且供血儿存在严重异常多普勒表现的病例,为45.4%(64/141)。

临床怎么用

  • 激光术前评估可关注Quintero分期的大组划分(Ⅰ-Ⅱ期 vs Ⅲ-Ⅳ期),而非细分期别。
  • Ⅲ期供血儿多普勒严重异常者双胎存活率最低,咨询时需重点告知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the perinatal outcome of monochorionic twin pregnancies with twin-twin transfusion syndrome (TTTS), according to the disease severity, defined using Quintero staging, after treatment with fetoscopic laser surgery. METHODS: This was a single-center study of 1020 consecutive cases with severe TTTS, which were treated with fetoscopic laser surgery. During the study period from January 1995 to March 2013, the participants were included at a mean ± SD gestational age of 20.8 ± 2.2 weeks. Perinatal survival analysis, including the rates of double survival and survival of at least one fetus, was undertaken according to the Quintero staging system. For blockwise comparisons of data, the whole population was divided into five chronologically consecutive study subgroups of 200 patients in each of the first four subgroups and 220 in the last one. RESULTS: For the entire study population with known outcome (n = 1019), the rate of pregnancy with double fetal survival was 69.0% (127/184) in Stage-I, 71.4% (257/360) in Stage-II, 55.4% (236/426) in Stage-III and 51.0% (25/49) in Stage-IV TTTS cases. At least one twin survived in 91.3% (168/184) of pregnancies with Stage-I, 89.7% (323/360) of those with Stage-II, 83.1% (354/426) of those with Stage-III and 77.6% (38/49) of those with Stage-IV TTTS. The rates of double survival and survival of at least one fetus were both significantly higher in Stage-II TTTS compared with those in Stage-III TTTS cases (P < 0.001 and P = 0.011, respectively). Survival rates between pregnancies with Stage-I vs Stage-II TTTS and between those with Stage-III vs Stage-IV TTTS were not significantly different. Therefore, we combined pregnancies with Stage-I or Stage-II TTTS, and those with Stage-III or Stage-IV TTTS. The double survival rate was 70.6% (384/544) in combined Stage-I and Stage-II vs 54.9% (261/475) in combined Stage-III and Stage-IV TTTS cases (P < 0.001). At least one twin survived in 90.3% (491/544) of pregnancies with Stage-I or Stage-II TTTS vs 82.5% (392/475) in those with Stage-III or Stage-IV TTTS (P < 0.001). The double survival rate increased between the first and the last consecutive study subgroups from 59.8% (55/92) to 75.0% (96/128) (adjusted odds ratio (aOR)linear trend , 1.26 (95% CI, 1.01-1.56); P = 0.037) in pregnancies with Stage-I or Stage-II TTTS and from 41.7% (45/108) to 62.0% (57/92) (aORlinear trend , 1.21 (95% CI, 0.98-1.50); P = 0.082) in those with Stage-III or Stage-IV TTTS. Double survival rate was the lowest for Stage-III cases in which the donor twin was affected by severely abnormal Doppler findings (45.4% (64/141)). CONCLUSIONS: Double survival and survival of at least one fetus in monochorionic twin pregnancies with TTTS were related significantly to Quintero stage. However, our data show that the differentiation between Stages I vs II and Stages III vs IV does not have any significant prognostic implication for perinatal survival. © 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Bamberg C, Diehl W, Diemert A, et al. Differentiation between TTTS Stages I vs II and III vs IV does not affect probability of double survival after laser therapy. Ultrasound Obstet Gynecol. 2021. PMID: 32959919. doi:10.1002/uog.23131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。